D-galactose Model
D-galactose Model - Related Videos
14:18
Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro
0 Views •
Cited by 4 •
2023
This study provides experimental data for treating immunoglobulin A nephropathy (IgAN) with Dioscin (DIO), the active ingredient of Dioscoreae Nipponicae Rhizoma (DNR), and a paradigm for studying herbal medicine's effects and underlying mechanisms in vivo and in vitro.
14:09
Genetic Studies of Human DNA Repair Proteins Using Yeast as a Model System
0 Views •
Cited by 2 •
2010
Genetic studies in yeast can be employed to investigate the molecular and cellular functions of human genes in cellular DNA metabolism. Methods are described for the genetic characterization of the human WRN gene product defective in the premature aging disorder Werner syndrome in functionally conserved pathways using yeast as a tractable model system.
07:23
Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification
0 Views •
Cited by 24 •
2016
We present a protocol to dissect and culture embryonic day 15 (E15) murine metatarsal bones. This highly physiological ex vivo model of endochondral ossification provides conditions closer to the in vivo situation than cells in monolayer or 3D culture and is a vital tool for investigating bone growth and development.
09:50
Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
0 Views •
Cited by 41 •
2015
The aim of this protocol is to expose human organotypic 3D bronchial and nasal tissue models to mainstream cigarette smoke (CS) at the air-liquid interface. The impact of CS on the tissues is then investigated using a cytochrome P450 activity assay, a cilia beating measurement, and a systems biology approach.
12:31
In Vivo Modeling of the Morbid Human Genome using Danio rerio
0 Views •
Cited by 66 •
2013
Here, we present a systematic approach for developing physiologically relevant, sensitive and specific in vivo assays for interpreting variation in human pathology. Transient genetic manipulation via microinjection of WT and mutant human mRNA and morpholino (MO) antisense oligonucleotides harness the tractability of the developing zebrafish embryo to rapidly assay pathogenic mutations, especially, but not exclusively, in the context of human developmental disorders.
FAQs
Repeated exposure at elevated doses promotes oxidative stress, which can disrupt tissue and organ function. It also supports the accumulation of advanced glycation end products, molecules associated with aging-related damage, and contributes to inflammatory changes. Together, these processes create measurable biological disturbances that researchers can examine as selected features of aging and age-related disease.
Advanced glycation end products are one of the major changes promoted by repeated D-galactose administration. Their accumulation provides a biochemical indicator of processes associated with aging and tissue impairment. Measuring this response helps investigators connect the administered treatment with molecular changes and evaluate whether an intervention alters a feature relevant to age-related disease.
Inflammatory changes form part of the biological response produced by repeated D-galactose exposure. They may accompany oxidative stress and advanced glycation end product accumulation, contributing to impaired tissue or organ function. Including inflammatory outcomes allows studies to examine aging-related mechanisms more broadly rather than relying on a single biochemical or functional measurement.
The model reproduces selected features of aging rather than the full complexity of human aging. Its changes arise from repeated administration of elevated D-galactose doses, so findings must be interpreted within that experimental context. This limitation makes the system useful for focused mechanistic and treatment studies, but it does not establish that every human aging process is represented.
A typical study repeatedly administers D-galactose to laboratory animals at an elevated dose, then evaluates changes relevant to the research question. Investigators may collect cognitive, biochemical, and histological outcomes to determine whether aging-related alterations have developed. Careful control of dosing and consistent outcome assessment are essential for making comparisons between experimental groups.
Studies can assess cognitive changes, biochemical indicators, and histological findings. Cognitive measurements address functional effects, biochemical analyses examine processes such as oxidative stress or advanced glycation end product accumulation, and histology evaluates tissue-level alterations. Using several outcome types provides complementary evidence about how the treatment affects function, molecular status, and tissue or organ condition.
Because the system produces measurable oxidative, glycation-related, inflammatory, cognitive, biochemical, and histological changes, researchers can test whether a candidate intervention modifies selected outcomes. The model is therefore useful for investigating mechanisms and screening therapeutic approaches in medicine. Results still require cautious interpretation because improvement in one feature does not represent reversal of all human aging processes.